Faculty profile

Michael Hill

ResearcherClinical NeurosciencesUniversity of Calgary

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses and email address may be missing. Find their university profile.

Michael Hill

Researcher

Clinical Neurosciences

Health Sciences

University of Calgary

Calgary, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
12 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 20 research grants (20 CIHR), most recently in 2026.
Supervised 3 trainees who won CIHR awards, most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Stroke Thrombolysis Acute Ischemic Stroke Randomized Controlled Trial Ischemic Stroke Clinical Trials Digital Health Patient-Reported Outcomes

Latest papers

Contemporary achievement of guideline recommendations for blood pressure management after stroke in the CONVINCE trial.
European stroke journal · 2026
Health Economic Impact of Incomplete Reperfusion Patterns After Endovascular Thrombectomy in Acute Ischemic Stroke.
Clinical neuroradiology · 2026
Health economic impact of Nerinetide in addition to mechanical thrombectomy without concurrent alteplase.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2026 · senior author

All 23 publications

Latest funding

ACT-RECOVER: Automated, neuroimaging-guided prediction of recovery and treatment complications in acute ischemic stroke
CIHR · 2026 · Co-investigator
$765,000
Acute Clot Thrombolysis: Late-window Administration of Tenecteplase in Extended Acute Ischemic Stroke (ACT-LATE).
CIHR · 2026 · Co-investigator
$100,000
Blood transfusion as a risk factor for lobar intracerebral hemorrhage
CIHR · 2026 · Nominated PI
$120,000

All 56 grants and awards

23 publications.

Contemporary achievement of guideline recommendations for blood pressure management after stroke in the CONVINCE trial.

Synnott P, Walsh C, Weimar C, Purroy F, Price C, Fonseca AC, Hill M, Jatuzis D, Kõrv J, Kruuse C, Mikulik R, Nederkoorn P, Czlonkowska A, Fischer U, Nabavi DG, Harbison J, Cassidy T, O'Connor M, Iversen HK, Adie K, Lemmens R, Kelly PJ, CONVINCE investigators

European stroke journal2026

DOI: 10.1093/esj/aakag051 PMID: 42418305

Health Economic Impact of Incomplete Reperfusion Patterns After Endovascular Thrombectomy in Acute Ischemic Stroke.

Stebner A, Cimflova P, Bosshart SL, Kunz WG, Bhogal P, Hill M, Goyal M, Ospel JM, ESCAPE-NA1 Investigators

Clinical neuroradiology2026

DOI: 10.1007/s00062-025-01524-5 PMID: 40874989

Health economic impact of Nerinetide in addition to mechanical thrombectomy without concurrent alteplase.

Ospel JM, Adams C, Tymianski M, Goyal M, Hill M

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences2026Senior author

DOI: 10.1177/15910199231193455 PMID: 37590087

Factors Influencing the Association of 24-hour National Institutes of Health Stroke Scale & 90-day Modified Rankin Score.

Stebner A, Bosshart SL, Demchuk A, Poppe A, Nogueira R, McTaggart R, Buck B, Ganesh A, Hill M, Goyal M, Ospel J

Clinical neuroradiology2025

DOI: 10.1007/s00062-024-01459-3 PMID: 39404848

Influence of recent randomized MeVO trials on current practice patterns and future role of MeVO thrombectomy.

Bosshart SL, Zhou Y, Stebner A, Kashani N, Goyal M, Hill M, Menon B, Almekhlafi M, Ganesh A, Singh N, Demchuk A, Liu J, Ospel JM

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences2025

DOI: 10.1177/15910199251389060 PMID: 41137680

Modified Rankin Scale at 90 Days Versus National Institutes of Health Stroke Scale at 24 Hours as Primary Outcome in Acute Stroke Trials.

Ospel JM, Brown S, Bosshart S, Stebner A, Uchida K, Demchuk A, Saver JL, White P, Muir KW, Dippel DWJ, Majoie CBLM, Jovin TG, Campbell BCV, Mitchell PJ, Bracard S, Guillemin F, Hill M, Goyal M, HERMES Investigators

Journal of the American Heart Association2025

DOI: 10.1161/jaha.124.037752 PMID: 39968801

How Do Quantitative Tissue Imaging Outcomes in Acute Ischemic Stroke Relate to Clinical Outcomes?

Ospel JM, Rinkel L, Ganesh A, Demchuk A, Heran M, Sauvageau E, Joshi M, Haussen D, Jayaraman M, Coutts S, Yu A, Puetz V, Iancu D, Bang OY, Tarpley J, Holmin S, Kelly M, Tymianski M, Hill M, Goyal M, ESCAPE-NA1 Investigators

Journal of stroke2024

DOI: 10.5853/jos.2023.02180 PMID: 38836272

Modeling diffusion-weighted imaging lesion expansion between 2 and 24 h after endovascular thrombectomy in acute ischemic stroke.

Rex N, Oueidat K, Ospel J, McDonough R, Rinkel L, Baird GL, Collins S, Jindal G, Alvin MD, Boxerman J, Barber P, Jayaraman M, Smith W, Amirault-Capuano A, Hill M, Goyal M, McTaggart R

Neuroradiology2024

DOI: 10.1007/s00234-024-03294-2 PMID: 38277008

Tenecteplase Versus Alteplase in Medium Vessel Occlusion Ischemic Stroke: A Secondary Analysis of the Alteplase Compared to Tenecteplase Randomized Trial

Bala F, Singh N, Ignacio K, Alhabli I, Ademola A, Alrohimi A, Khosravani H, Tkach A, Catanese L, Dowlatshahi D

Journal of Stroke202415 citationsOpen Access

DOI: 10.5853/jos.2023.03713 PMID: W4399248935

Modeling the Decay in Probability of Receiving Endovascular Thrombectomy on the Basis of Time From Stroke Onset.

Paydarfar DA, Holodinsky JK, Mazya MV, Hill M, Menon B, Jayaraman M, Kamal N

Stroke (Hoboken, N.J.)2023

DOI: 10.1161/svin.123.000932 PMID: 41585066

Something wrong or missing on this profile? Suggest a correction

Michael Hill

Research

Latest papers

Latest funding

Contemporary achievement of guideline recommendations for blood pressure management after stroke in the CONVINCE trial.

Health Economic Impact of Incomplete Reperfusion Patterns After Endovascular Thrombectomy in Acute Ischemic Stroke.

Health economic impact of Nerinetide in addition to mechanical thrombectomy without concurrent alteplase.

Factors Influencing the Association of 24-hour National Institutes of Health Stroke Scale & 90-day Modified Rankin Score.

Influence of recent randomized MeVO trials on current practice patterns and future role of MeVO thrombectomy.

Modified Rankin Scale at 90&#x2009;Days Versus National Institutes of Health Stroke Scale at 24 Hours as Primary Outcome in Acute Stroke Trials.

How Do Quantitative Tissue Imaging Outcomes in Acute Ischemic Stroke Relate to Clinical Outcomes?

Modeling diffusion-weighted imaging lesion expansion between 2 and 24&#xa0;h after endovascular thrombectomy in acute ischemic stroke.

Tenecteplase Versus Alteplase in Medium Vessel Occlusion Ischemic Stroke: A Secondary Analysis of the Alteplase Compared to Tenecteplase Randomized Trial

Modeling the Decay in Probability of Receiving Endovascular Thrombectomy on the Basis of Time From Stroke Onset.

Frequent collaborators

Mayank Goyal

Andrew Demchuk

Michael Hill

Mohammed Almekhlafi

Bijoy Menon

Aravind Ganesh

Michael Tymianski

Johanna Ospel

Adam Kirton

Alexandre Poppe

Brian Buck

Thalia Field

Gustavo Saposnik

Noreen Kamal

Nishita Singh

Kenneth Butcher

Wu Qiu

Sue Peters

Nishita Singh

Mary Dunbar

Bijoy Menon

Dar Dowlatshahi

Houman Khosravani

Eddy Lang

Mark Bayley

Angelo Mikrogianakis

Sean Dukelow

Janice Eng

Richard Swartz

Richard Aviv

Luciana Catanese

Houman Khosravani

Roger Zemek

Deborah Dewey

Modified Rankin Scale at 90 Days Versus National Institutes of Health Stroke Scale at 24 Hours as Primary Outcome in Acute Stroke Trials.

Modeling diffusion-weighted imaging lesion expansion between 2 and 24 h after endovascular thrombectomy in acute ischemic stroke.